Vergote V - Search Results

1

In vitro metabolic stability of obestatin: kinetics and identification of cleavage products.

Vergote V, Van Dorpe S, Peremans K, Burvenich C, De Spiegeleer B. Vergote V, et al. Peptides. 2008 Oct;29(10):1740-8. doi: 10.1016/j.peptides.2008.05.018. Epub 2008 Jul 3. Peptides. 2008. PMID: 18602197

2

LC-UV/MS characterization and DOE optimization of the iodinated peptide obestatin.

Vergote V, Baert B, Vandermeulen E, Peremans K, van Bree H, Slegers G, Burvenich C, De Spiegeleer B. Vergote V, et al. J Pharm Biomed Anal. 2008 Jan 7;46(1):127-36. doi: 10.1016/j.jpba.2007.10.005. Epub 2007 Oct 13. J Pharm Biomed Anal. 2008. PMID: 18024048

3

Impurity profiling quality control testing of synthetic peptides using liquid chromatography-photodiode array-fluorescence and liquid chromatography-electrospray ionization-mass spectrometry: the obestatin case.

De Spiegeleer B, Vergote V, Pezeshki A, Peremans K, Burvenich C. De Spiegeleer B, et al. Among authors: vergote v. Anal Biochem. 2008 May 15;376(2):229-34. doi: 10.1016/j.ab.2008.02.014. Epub 2008 Feb 23. Anal Biochem. 2008. PMID: 18342612

4

Development of peptide receptor binding assays: methods to avoid false negatives.

Vergote V, Van Dorpe S, Verbeken M, Burvenich C, Van de Wiele C, Banks WA, De Spiegeleer B. Vergote V, et al. Regul Pept. 2009 Nov 27;158(1-3):97-102. doi: 10.1016/j.regpep.2009.08.006. Epub 2009 Aug 23. Regul Pept. 2009. PMID: 19706310

5

In vitro metabolic stability of iodinated obestatin peptides.

De Spiegeleer B, Van Dorpe S, Vergote V, Wynendaele E, Pauwels E, Van De Wiele C, Garcia-Solis P, Solis-Sainz JC. De Spiegeleer B, et al. Among authors: vergote v. Peptides. 2012 Feb;33(2):272-8. doi: 10.1016/j.peptides.2011.12.010. Epub 2011 Dec 27. Peptides. 2012. PMID: 22222609 Free article.

6

Adsorption of peptides at the sample drying step: influence of solvent evaporation technique, vial material and solution additive.

Pezeshki A, Vergote V, Van Dorpe S, Baert B, Burvenich C, Popkov A, De Spiegeleer B. Pezeshki A, et al. Among authors: vergote v. J Pharm Biomed Anal. 2009 Apr 5;49(3):607-12. doi: 10.1016/j.jpba.2008.12.003. Epub 2008 Dec 11. J Pharm Biomed Anal. 2009. PMID: 19150589

7

Central administration of obestatin fails to show inhibitory effects on food and water intake in mice.

Van Dijck A, Van Dam D, Vergote V, De Spiegeleer B, Luyten W, Schoofs L, De Deyn PP. Van Dijck A, et al. Among authors: vergote v. Regul Pept. 2009 Aug 7;156(1-3):77-82. doi: 10.1016/j.regpep.2009.04.014. Epub 2009 May 5. Regul Pept. 2009. PMID: 19422857

8

Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability.

Svenson J, Vergote V, Karstad R, Burvenich C, Svendsen JS, De Spiegeleer B. Svenson J, et al. Among authors: vergote v. J Pharmacol Exp Ther. 2010 Mar;332(3):1032-9. doi: 10.1124/jpet.109.162826. Epub 2009 Dec 1. J Pharmacol Exp Ther. 2010. PMID: 19952307

9

Hydrophilic interaction LC of peptides: columns comparison and clustering.

Van Dorpe S, Vergote V, Pezeshki A, Burvenich C, Peremans K, De Spiegeleer B. Van Dorpe S, et al. Among authors: vergote v. J Sep Sci. 2010 Mar;33(6-7):728-39. doi: 10.1002/jssc.200900476. J Sep Sci. 2010. PMID: 20135706

10

Analysis of iodinated peptides by LC-DAD/ESI ion trap mass spectrometry.

Vergote V, Bodé S, Peremans K, Vanbree H, Baert B, Slegers G, Burvenich C, De Spiegeleer B. Vergote V, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 1;850(1-2):213-20. doi: 10.1016/j.jchromb.2006.11.028. Epub 2006 Dec 1. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17141583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters